MDXG MiMedx Group Inc.

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MARIETTA, Ga., April 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will participate in the following industry conferences this quarter to feature the latest scientific and clinical data supporting the use of its portfolio of Advanced Wound Care and Surgical Solutions.

“MIMEDX’s ongoing commitment to innovation and our expanding, best-in-class body of scientific and clinical evidence will be on full display at these high-profile conferences this spring,” stated Joseph H. Capper, MIMEDX Chief Executive Officer. “We are excited to share insights with leading wound care providers and key opinion leaders at the Diabetic Limb Salvage conference, as well as at SAWC Spring.”

Mr. Capper continued, “This year, we are also thrilled to be participating in Digestive Disease Week, a new industry conference for MIMEDX and one that demonstrates our continued commitment to drive awareness and adoption of our products in surgical settings, including gastrointestinal surgery.”

MedStar Georgetown University Hospital’s Diabetic Limb Salvage (DLS) Conference

April 10-12, 2025 | Washington, D.C. | Booth 103

Sponsored Lunch Symposium

Title: Climbing the Ladder or Taking the Elevator? Rethinking Limb Salvage Strategies

Date/Time: Thursday, April 10 / 12:20 – 1:10 p.m.

Speakers: Frank Lau, MD, FACS; Megan Oltmann, DPM, D.ABFAS, FACFAS

Symposium on Advanced Wound Care (SAWC) Spring 2025

April 30-May 4, 2025 | Grapevine, TX | Booth 800

Sponsored Lunch Symposium

Title: Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape

Date/Time: Thursday, May 1 / 12:00 – 1:30 p.m.

Speakers: Paul Kim, DPM, MS, FACFAS; Nicolas Mouawad, MD, MPH, MBA, DFSVS, FRCS, FACS, RPVI; Scott R. Boynton, DPM, FACFAS

Digestive Disease Week (DDW) 2025

May 3-6, 2025 | San Diego, CA  

Oral Presentation

Title: Hospital Readmissions & Anastamotic Leaks with the use of Amniotic Tissues in Colorectal Surgery

Date/Time: Tuesday, May 6 / 4:00 p.m.

Speaker: Bidhan Das, MD

About MIMEDX

MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit .

About DLS

This annual conference emphasizes a multidisciplinary team approach, equipping each member of the healthcare team with the education and resources needed to heal wounds and prevent amputations. The program features a distinguished international faculty and underscores the importance of a multispecialty approach in limb salvage. Designed for healthcare practitioners across all specialties, the course promotes evidence-based practices with a focus on actionable insights, innovative techniques, and improved patient outcomes.

About SAWC

The Symposium on Advanced Wound Care meeting (SAWC), serves as a forum to connect the entire wound care team—physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians—with the foremost experts in wound care to improve patient outcomes through education. No other wound care conference offers the level of education, advanced state-of-the-art clinical reviews, and emerging research findings.

About Digestive Disease Week

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW is an in-person and online meeting from May 3-6, 2025. The meeting showcases more than 4,400 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at

Contact:

Matt Notarianni

Investor Relations

470-304-7291



EN
10/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MiMedx Group Inc.

 PRESS RELEASE

MIMEDX Announces Publication in the Journal of Inflammation Focused on...

MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro Study investigates the influence of MIMEDX DHACM and LHACM products on inflammatory response, which supports the healing cascade and tissue repair MARIETTA, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated human amnion chorion membrane (DHACM...

 PRESS RELEASE

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of EPIEFFECT When Compared to Standard of Care (“SOC”) Publication Adds to Large Compendium of Evidence for MIMEDX’s Leading Product Portfolio Trial Enrollment Ongoing MARIETTA, Ga., Nov. 13, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the publication of interim results from its CAMPAIGN trial, a randomized controlled trial (“RCT”) designed to...

 PRESS RELEASE

MIMEDX to Participate in Upcoming Investor Conferences

MIMEDX to Participate in Upcoming Investor Conferences MARIETTA, Ga., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum 16th Annual Alpha Select Conference | New York, NYTuesday, November 18, 20251:1 sessions Canaccord MedTech, Diagnostics and Digital Health & Services Forum | New York, NYThursday, November 20, 20251:1 sessions Investors interested in meeting with senior management at these events may contact their resp...

 PRESS RELEASE

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule Company is Well Positioned to Continue to Compete and Grow MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”) final rule, which was published on Friday. “Over the last several years, we have actively engaged with numerous stakeholders to advocate for much-needed reform of the Medicare reimbursement system for skin substitutes. CMS i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch